Schrödinger jumps on the PRMT5 bandwagon
Meanwhile, Bristol Myers Squibb hands back two mystery projects.
Meanwhile, Bristol Myers Squibb hands back two mystery projects.
Initial data on Amgen’s AMG 193 give some Tango investors a headache.
The acquisition brings closure for Mirati at last, though some investors will feel disappointed.
But Repare and Black Diamond still have rebuilding to do.